Roche Holding AG
0QQ6.LFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
77,994
Cost of Revenue
20,354
Gross Profit
57,640
Gross Margin
73.9%
Operating Income
16,771
Operating Margin
21.5%
Net Income
10,346
Net Margin
13.3%
EPS (Basic)
$13.00
EPS (Diluted)
$13.00
EBITDA
20,774
EBITDA Margin
26.6%
2023
12/31/2023
Revenue
75,551
Cost of Revenue
20,446
Gross Profit
55,105
Gross Margin
72.9%
Operating Income
19,244
Operating Margin
25.5%
Net Income
14,373
Net Margin
19.0%
EPS (Basic)
$18.00
EPS (Diluted)
$18.00
EBITDA
23,016
EBITDA Margin
30.5%
2022
12/31/2022
Revenue
79,101
Cost of Revenue
23,546
Gross Profit
55,555
Gross Margin
70.2%
Operating Income
22,719
Operating Margin
28.7%
Net Income
15,526
Net Margin
19.6%
EPS (Basic)
$19.00
EPS (Diluted)
$19.00
EBITDA
26,000
EBITDA Margin
32.9%
2021
12/31/2021
Revenue
78,501
Cost of Revenue
24,629
Gross Profit
53,873
Gross Margin
68.6%
Operating Income
21,604
Operating Margin
27.5%
Net Income
17,413
Net Margin
22.2%
EPS (Basic)
$20.00
EPS (Diluted)
$20.00
EBITDA
27,735
EBITDA Margin
35.3%
2020
12/31/2020
Revenue
72,904
Cost of Revenue
20,443
Gross Profit
52,461
Gross Margin
72.0%
Operating Income
22,161
Operating Margin
30.4%
Net Income
17,869
Net Margin
24.5%
EPS (Basic)
$21.00
EPS (Diluted)
$21.00
EBITDA
28,711
EBITDA Margin
39.4%